Skip to main content
Top
Published in: Quality of Life Research 11/2019

Open Access 01-11-2019 | Muscular Dystrophy

Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD)

Authors: Michelle K. White, Mindy Leffler, Kaitlin Rychlec, Chris Jones, Christine McSherry, Linsey Walker, Mark Kosinski

Published in: Quality of Life Research | Issue 11/2019

Login to get access

Abstract

Purpose

The Duchenne muscular dystrophy (DMD) Video Assessment requires a caregiver to record six videos of their ambulatory child performing physical activities using a smartphone application (app). Innovative assessments that combine a performance measure, technology, and an observer require new approaches to content validation studies. This study presents a novel approach to establish the feasibility and content validity of the Video Assessment and usability of the app.

Methods

Interviews used concept elicitation and an adapted cognitive debriefing approach. Interviews were conducted with 8 clinicians who reviewed training materials prior to the interview and provided feedback on the appropriateness and usefulness of the DMD Video Assessment and the relevance of the physical activities. Four caregivers reviewed training materials and used the app to record their child performing the physical activities prior to the interview. Researchers reviewed the recordings against a checklist to identify discrepancies in caregivers’ understanding of the training materials prior to an interview. During the interview, caregivers commented on comprehension of the materials, appropriateness of the activities, and feasibility of recording the videos.

Results

Clinicians found the DMD Video Assessment and materials appropriate and useful for assessing disease progression and treatment response. Caregivers found the activities appropriate and the training materials and app easy to understand and use. Feedback resulted in changes to the training materials, but not the activities or videotaping procedure.

Conclusions

Researchers used an innovative methodological approach that adapted traditional methods of content validation for the purpose of evaluating a technology-based performance measure in its totality. While future studies should be conducted with a larger, more diverse sample, these study findings add to our understanding of the content validity of the DMD Video Assessment.
Footnotes
1
Leffler M., McSherry C. (2017). Caregiver assessments for the ESSENCE clinical trial program: report on Casimir validation efforts. [Summary available from author upon request.].
 
2
See footnote 1.
 
3
Because the disease trajectory of DMD includes loss of ambulation, a non-ambulatory assessment is under development.
 
4
Caregivers provided written consent at interview location.
 
Literature
5.
go back to reference Emery, A. E. (1991). Population frequencies of inherited neuromuscular diseases—A world survey. Neuromuscular Disorders: NMD, 1(1), 19–29.CrossRef Emery, A. E. (1991). Population frequencies of inherited neuromuscular diseases—A world survey. Neuromuscular Disorders: NMD, 1(1), 19–29.CrossRef
13.
go back to reference McDonald, C., Reha, A., Elfring, G. L., Peltz, S. W., & Spiegel, R. (2014). TP 5: Timed function tests and other physical function outcomes in Ataluren-treated patients with nonsense mutation Duchenne Muscular Dystrophy (nmDMD). Neuromuscular Disorders, 24(9), 861.CrossRef McDonald, C., Reha, A., Elfring, G. L., Peltz, S. W., & Spiegel, R. (2014). TP 5: Timed function tests and other physical function outcomes in Ataluren-treated patients with nonsense mutation Duchenne Muscular Dystrophy (nmDMD). Neuromuscular Disorders, 24(9), 861.CrossRef
17.
go back to reference US Food and Drug Administration. (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring: US Food and Drug Administration. US Food and Drug Administration. (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring: US Food and Drug Administration.
18.
go back to reference Patrick, D. L., Burke, L. B., Gwaltney, C. J., et al. (2011). Content validity—Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: Part 2—Assessing respondent understanding. Value in Health, 14(8), 978–988. https://doi.org/10.1016/j.jval.2011.06.013.CrossRefPubMed Patrick, D. L., Burke, L. B., Gwaltney, C. J., et al. (2011). Content validity—Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: Part 2—Assessing respondent understanding. Value in Health, 14(8), 978–988. https://​doi.​org/​10.​1016/​j.​jval.​2011.​06.​013.CrossRefPubMed
Metadata
Title
Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD)
Authors
Michelle K. White
Mindy Leffler
Kaitlin Rychlec
Chris Jones
Christine McSherry
Linsey Walker
Mark Kosinski
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 11/2019
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02245-2

Other articles of this Issue 11/2019

Quality of Life Research 11/2019 Go to the issue